Ironwood Pharmaceuticals IncIRWD
What Ironwood Pharmaceuticals Inc does.
We are a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. We are focused on the development and commercialization of innovative product opportunities in areas of significant unmet need, leveraging our demonstrated expertise and capabilities in GI and rare diseases.
LINZESS ® (linaclotide), our commercial product, is the first product approved by the United States Food and Drug Administration, or U.S. FDA, in a class of GI medicines called guanylate cyclase type C agonists, or GC-C agonists, and is indicated for the treatment, in the U.S., of irritable bowel syndrome with constipation, or IBS-C, in adults and pediatric patients 7 years of age and older, chronic idiopathic constipation, or CIC, in adults, and functional constipation, or FC, in pediatric patients ages 6-17 years-old. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA® for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $389.5M | $413.8M | $410.6M | $442.7M | $351.4M | $296.2M |
| Net income | $106.2M | $528.4M | $175.1M | -$1.0B | $880,000 | $24.0M |
| Free cash flow | $167.0M | $261.6M | $273.6M | $183.2M | $103.4M | $127.0M |
More on IRWD.
- Ironwood Pharmaceuticals Inc summary
- Ironwood Pharmaceuticals Inc financial statements
- Ironwood Pharmaceuticals Inc key metrics
- Ironwood Pharmaceuticals Inc health scores and style box
- Ironwood Pharmaceuticals Inc earnings
- Ironwood Pharmaceuticals Inc dividends
- Ironwood Pharmaceuticals Inc valuation
- Ironwood Pharmaceuticals Inc ownership and insiders
- Ironwood Pharmaceuticals Inc peers
Figures from Ironwood Pharmaceuticals Inc's filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.